“We cannot endorse the Tasmanian Drug Strategy 2022-2027 as it stands as we believe that it will not drive the change that the sector, and Tasmanians who need support, require.
It requires further development, and we stand ready to work closely with the State Government to assist in the development of strategy that will lead to meaningful change in how Tasmanians use drugs, how they seek help if they want it, and how the community supports them.”
The ATDC acknowledges the Tasmanian Aboriginal community as the traditional custodians of Tasmania and recognises the importance of working together.
The ATDC gratefully acknowledges the financial and other support provided by the Tasmanian Department of Health, Primary Health Tasmania and the Australian Government Department of Health and Aged Care.
The ATDC is a Quality Innovation Performance (QIP) accredited organisation against the Australian Service Excellence Standards (ASES).
